Managers / Q1 2025 · view latest →
Green Alpha Advisors, LLC
CIK 0001439207 · 136 2ND AVENUE, UNIT D, NIWOT, CO, 80544 · 3039937856
Summary
Green Alpha Advisors, LLC reported $94M in U.S.-listed holdings across 112 positions for Q1 2025.
Its largest position, IBM, represents 6.1% of the portfolio.
Compared with Q4 2024, the fund opened 1 new position and exited 36.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 94.0% · $88M
- Other · 5.5% · $5M
- ETP · 0.4% · $396,700
Quarter-over-Quarter Changes full breakdown →
vs Q4 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ARCTARCTURUS THERAPEUTICS HLDGS | NEW | +27.2K | 27.2K | +$288,376 | $288,376 |
| ARRYARRAY TECHNOLOGIES INC | ADDED | +46.6K | 61.9K | +$208,995 | $301,244 |
| WOLF*WOLFSPEED INC | ADDED | +48.6K | 71.2K | +$67,560 | $217,903 |
| NXTNEXTRACKER INC | ADDED | +19.9K | 29.3K | +$893,301 | $1M |
| QSQUANTUMSCAPE CORP | ADDED | +100.3K | 156.0K | +$359,952 | $648,993 |
| RXRXRECURSION PHARMACEUTICALS IN | ADDED | +111.7K | 178.9K | +$492,338 | $946,238 |
| CRBUCARIBOU BIOSCIENCES INC | ADDED | +251.3K | 432.3K | +$106,880 | $394,756 |
| CRISPR THERAPEUTICS AG | ADDED | +32.7K | 57.4K | +$982,598 | $2M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2025
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $102M | 107 | Apr 7, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $109M | 115 | Jan 7, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $104M | 102 | Oct 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $105M | 109 | Aug 1, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $94M | 112 | Apr 9, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $125M | 147 | Jan 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $127M | 141 | Oct 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $124M | 138 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $138M | 142 | Apr 10, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $139M | 151 | Jan 5, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $130M | 156 | Oct 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $152M | 153 | Jul 6, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $143M | 150 | Apr 6, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $120M | 144 | Jan 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $118M | 141 | Oct 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $435M | 149 | Jul 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $148M | 136 | Apr 19, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $148M | 124 | Jan 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $145M | 126 | Oct 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $147M | 127 | Jul 22, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.